GP
Gilgamesh Pharma Inc.
SEC filingPharmaceuticals · New York, NY
Amount raised$2.3Msold at filing
Total offering$15M$12.8M still open
Investors in the raise3count reported to the SEC
FiledMar 31, 2026first sale Mar 27, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Amy KruseDirector
Jonathan SpornExecutive Officer, Director
Phil SkolnickDirector
Zia HuqueDirector
Robert BermanDirector
Andrew KruegelExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.